Venture Life acquires FemiClear & CUROXEN for up to $28 million
LONDON: Venture Life (AIM: VLG), a recognised leader in proactive longevity, health innovation and global commercialisation within the consumer healthcare sector, announced the acquisition of FemiClear, and CUROXEN (together with FemiClear, the “Brands”), from OrganiCare Nature’s Sciences, LLC (“OrganiCare”) for a total consideration of up to…